אימונוגניות
הערות שוליים

↑  Leroux-Roels, Geert; Bonanni, Paolo; Tantawichien, Terapong; Zepp, Fred (באוגוסט 2011). "Vaccine development". Perspectives in Vaccinology. 1 (1): 115–150. doi:10.1016/j.pervac.2011.05.005. {{cite journal}}:  (עזרה)
↑  De Groot, Anne S.; Scott, David W. (בנובמבר 2007). "Immunogenicity of protein therapeutics". Trends in Immunology. 28 (11): 482–490. doi:10.1016/j.it.2007.07.011. PMID 17964218. {{cite journal}}:  (עזרה)
↑  Baker, Matthew; Reynolds, Helen M.; Lumicisi, Brooke; Bryson, Christine J. (באוקטובר 2010). "Immunogenicity of protein therapeutics: The key causes, consequences and challenges". Self/Nonself. 1 (4): 314–322. doi:10.4161/self.1.4.13904. PMC 3062386. PMID 21487506. {{cite journal}}:  (עזרה)
↑  Lindsey, Benjamin B; Armitage, Edwin P; Kampmann, Beate; de Silva, Thushan I (באפריל 2019). "The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review" (PDF). The Lancet Infectious Diseases. 19 (4): e110–e119. doi:10.1016/S1473-3099(18)30490-0. PMID 30553695. {{cite journal}}:  (עזרה)
↑  Nic Lochlainn, Laura M; de Gier, Brechje; van der Maas, Nicoline; Strebel, Peter M; Goodman, Tracey; van Binnendijk, Rob S; de Melker, Hester E; Hahné, Susan J M (בנובמבר 2019). "Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis". The Lancet Infectious Diseases. 19 (11): 1235–1245. doi:10.1016/S1473-3099(19)30395-0. PMC 6838664. PMID 31548079. {{cite journal}}:  (עזרה)
↑  Samson, Sandrine I.; Leventhal, Phillip S.; Salamand, Camille; Meng, Ya; Seet, Bruce T.; Landolfi, Victoria; Greenberg, David; Hollingsworth, Rosalind (4 במרץ 2019). "Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis". Expert Review of Vaccines. 18 (3): 295–308. doi:10.1080/14760584.2019.1575734. PMID 30689467. {{cite journal}}:  (עזרה)
↑  Dowds, C. Marie; Kornell, Sabin-Christin; Blumberg, Richard S.; Zeissig, Sebastian (1 בינואר 2014). "Lipid antigens in immunity". Biological Chemistry. 395 (1): 61–81. doi:10.1515/hsz-2013-0220. PMC 4128234. PMID 23999493. {{cite journal}}:  (עזרה)
↑  Stephen, Tom Li; Groneck, Laura; Kalka-Moll, Wiltrud Maria (2010). "The Modulation of Adaptive Immune Responses by Bacterial Zwitterionic Polysaccharides". International Journal of Microbiology. 2010: 917075. doi:10.1155/2010/917075. PMC 3017905. PMID 21234388.
↑  Fishman, Jonathan M.; Wiles, Katherine; Wood, Kathryn J. (2015). "The Acquired Immune System Response to Biomaterials, Including Both Naturally Occurring and Synthetic Biomaterials".  In Badylak, Stephen F. (ed.). Host Response to Biomaterials. Academic Press. pp. 151–187. doi:10.1016/B978-0-12-800196-7.00008-6. ISBN 978-0-12-800196-7.
1 2 3  Weber, Constanze A.; Mehta, Preema J.; Ardito, Matt; Moise, Lenny; Martin, Bill; De Groot, Anne S. (30 בספטמבר 2009). "T cell epitope: Friend or Foe? Immunogenicity of biologics in context". Advanced Drug Delivery Reviews. 61 (11): 965–976. doi:10.1016/j.addr.2009.07.001. PMC 7103283. PMID 19619593. {{cite journal}}:  (עזרה)
↑  Singh, Surjit; Kumar, Nitish K.; Dwiwedi, Pradeep; Charan, Jaykaran; Kaur, Rimplejeet; Sidhu, Preeti; Chugh, Vinay K. (9 באוקטובר 2018). "Monoclonal Antibodies: A Review". Current Clinical Pharmacology. 13 (2): 85–99. doi:10.2174/1574884712666170809124728. PMID 28799485. {{cite journal}}:  (עזרה)
↑  Schnyder, Benno; Pichler, Werner J. (2009). "Mechanisms of Drug-Induced Allergy". Mayo Clinic Proceedings. 84 (3): 268–272. doi:10.4065/84.3.268. PMC 2664605. PMID 19252115.
↑  Doevendans, Erik; Schellekens, Huub (5 במרץ 2019). "Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies". Antibodies. 8 (1): 21. doi:10.3390/antib8010021. PMC 6640699. PMID 31544827. {{cite journal}}:  (עזרה)
↑  Stryjewska, Agnieszka; Kiepura, Katarzyna; Librowski, Tadeusz; Lochyński, Stanisław (בספטמבר 2013). "Biotechnology and genetic engineering in the new drug development. Part II. Monoclonal antibodies, modern vaccines and gene therapy". Pharmacological Reports. 65 (5): 1086–1101. doi:10.1016/s1734-1140(13)71467-1. PMID 24399705. {{cite journal}}:  (עזרה)
↑  Lonberg, Nils; Huszar, Dennis (בינואר 1995). "Human Antibodies from Transgenic Mice". International Reviews of Immunology. 13 (1): 65–93. doi:10.3109/08830189509061738. PMID 7494109. {{cite journal}}:  (עזרה)
↑  Pecoraro, Valentina; De Santis, Elena; Melegari, Alessandra; Trenti, Tommaso (ביוני 2017). "The impact of immunogenicity of TNFα inhibitors in autoimmune inflammatory disease. A systematic review and meta-analysis". Autoimmunity Reviews. 16 (6): 564–575. doi:10.1016/j.autrev.2017.04.002. PMID 28411169. {{cite journal}}:  (עזרה)
↑  Kuriakose, Anshu; Chirmule, Narendra; Nair, Pradip (2016). "Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications". Journal of Immunology Research. 2016: 1–18. doi:10.1155/2016/1298473. PMC 4942633. PMID 27437405.
הבהרה: המידע בוויקיפדיה נועד להעשרה בלבד ואינו מהווה ייעוץ רפואי.
גורמים המשפיעים על אימונוגניות של נוגדנים מונוקלונליים